|
市場調査レポート
心臓血管薬物治療の進展
Advances in Cardiovascular Drug Therapies
|
Abstract
This research service outlines the key global developments in cardiovascular
drug therapies.
Table of Contents
1 EXECUTIVE SUMMARY
- Scope and Methodology
- Scope and Segmentation
- Methodology
- Industry Overview
- Brief Summary of Cardiovascular Drug Industry
- Key Findings and Noteworthy Developments
2 TECHNOLOGY ADOPTION FACTOR ANALYSIS
- Emerging Trends in Cardiovascular Drug Therapy; Research and Development
- CVDs and Drug Classes
- Emerging Trends in Cardiovascular Drug Therapy
- Cardiovascular Pharmacogenomics--A Major Trend in Cardiovascular Research
- Emerging Trends in Cardiovascular Biomarkers--Diagnostic; Prognostic;
and Therapeutic Insights
- Emerging Molecular Therapeutics and Their Impact on CVD Drug Development
- Strategic Analysis and Recommendations
- Analysis of Drivers for Cardiovascular Pharmaceutical Industry
- Impact of Challenges and Restraints on Cardiovascular Pharmaceuticals
- Product Life Cycle Analysis and Strategic Recommendations
- Opportunity Analysis
- Acquisitions; Partnerships; and Technology Licensing between Companies
and Research Organizations
3 GLOBAL DEVELOPMENTS IN CARDIOVASCULAR DRUGS
- Corporate Developments--World
- Blockbuster Drug to Treat Hypercholesterolemia--USA
- Novel Antisense Drug for Cholesterol Management--USA
- Novel Direct Acting Aptamer-Based Anticoagulant--USA
- Novel Drug Candidates to Treat Cardiac Reperfusion Induced Heart
Failure--Israel
- Breakthrough Technology Platform and Novel Drug to Increase HDL
Levels--Canada
- Cardioprotective Effects of a Naturally Occurring Peptide--USA
- Novel Drugs for Acute Coronary Syndrome--Canada
- Sonolysis-Based tPA Therapy for Ischemic Stroke Patients--USA
- DNA-Based Therapeutic to Treat Angina--USA
- Selective Thyroid Hormone Agonist Lowers LDL Levels--Sweden
- Novel Drug to Treat Diabetic and Nondiabetic Heart Failure--New Zealand
- Novel Drug with Better Safety and Tolerability Profile for Atrial
Fibrillation--USA
- Academic Developments--World
- PPAR-Delta as a Potential Drug Target for Treating Atherosclerosis--USA
- Discovery of Genetic Link to Bad Cholesterol Raises Hope for Specific
Therapy--UK
- Potential of a Novel Compound to Reduce the Impact of Heart Attack in
Humans--USA
4 INTELLECTUAL PROPERTY SCENARIO AND KEY INDUSTRY PARTICIPANTS
- Patent Details and Patent Analysis
- Corporate Patents
- Academic Patents
- Contact Details
- Industry Contacts
- University Contacts
5 DECISION SUPPORT DATABASE
- Decision Support Tables
- Hypertension Prevalence--World (2002 to 2012)
- New Cases of Heart Attack--World (2002 to 2012)
- New Cases of Stroke--World (2002 to 2012)
- Population Aged 65 Years and Above--World (2002 to 2012)
- Prevalence of Diabetes--World (2002 to 2012)
- Pharmaceutical R&D Expenditure--World (2002 to 2012)
|
